Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Upadacitinib may effectively treat alopecia areata without side effects.

Oral processed egg yolk improves hair regrowth and quality in alopecia patients.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

New alopecia treatments aim for better results and fewer side effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The document is a detailed medical reference on skin and genetic disorders.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.